 Lyndsey DuBose
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Stiffness | 13 | 2023 | 407 | 2.670 |
Why?
| | Aging | 10 | 2023 | 1620 | 1.350 |
Why?
| | Vascular Diseases | 2 | 2022 | 230 | 1.210 |
Why?
| | White Matter | 2 | 2018 | 104 | 1.060 |
Why?
| | Cardiorespiratory Fitness | 3 | 2022 | 35 | 1.000 |
Why?
| | Cerebrovascular Circulation | 3 | 2022 | 220 | 0.870 |
Why?
| | Menopause | 2 | 2023 | 271 | 0.860 |
Why?
| | Perimenopause | 1 | 2023 | 61 | 0.810 |
Why?
| | Hypercapnia | 1 | 2022 | 51 | 0.800 |
Why?
| | Carotid Arteries | 5 | 2023 | 180 | 0.790 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2022 | 184 | 0.780 |
Why?
| | Cognitive Dysfunction | 2 | 2022 | 284 | 0.650 |
Why?
| | Memory, Short-Term | 2 | 2020 | 225 | 0.610 |
Why?
| | Cognition | 4 | 2021 | 989 | 0.590 |
Why?
| | Blood Flow Velocity | 2 | 2022 | 387 | 0.590 |
Why?
| | Educational Status | 1 | 2019 | 412 | 0.590 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2019 | 141 | 0.560 |
Why?
| | Endothelium, Vascular | 6 | 2023 | 843 | 0.520 |
Why?
| | Pre-Eclampsia | 3 | 2023 | 165 | 0.520 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 254 | 0.510 |
Why?
| | Executive Function | 1 | 2019 | 379 | 0.500 |
Why?
| | Cardiovascular Diseases | 5 | 2023 | 1727 | 0.440 |
Why?
| | Pulse Wave Analysis | 7 | 2023 | 207 | 0.430 |
Why?
| | Blood Pressure | 8 | 2023 | 1530 | 0.420 |
Why?
| | Arterial Pressure | 2 | 2023 | 99 | 0.370 |
Why?
| | Aorta | 4 | 2021 | 386 | 0.350 |
Why?
| | Testosterone | 2 | 2022 | 343 | 0.320 |
Why?
| | Sympathetic Nervous System | 2 | 2019 | 171 | 0.300 |
Why?
| | Vasodilation | 3 | 2020 | 415 | 0.290 |
Why?
| | Middle Aged | 15 | 2023 | 26757 | 0.290 |
Why?
| | Female | 18 | 2023 | 59507 | 0.260 |
Why?
| | Aged | 11 | 2023 | 19094 | 0.260 |
Why?
| | Baroreflex | 2 | 2022 | 54 | 0.240 |
Why?
| | Humans | 26 | 2023 | 114756 | 0.240 |
Why?
| | Pregnancy Trimester, Third | 2 | 2023 | 78 | 0.230 |
Why?
| | Estrogens | 2 | 2023 | 312 | 0.220 |
Why?
| | Peroxynitrous Acid | 1 | 2022 | 11 | 0.210 |
Why?
| | Exercise | 3 | 2023 | 1644 | 0.210 |
Why?
| | Brachial Artery | 3 | 2020 | 176 | 0.200 |
Why?
| | Mentors | 1 | 2023 | 156 | 0.200 |
Why?
| | Vascular Remodeling | 2 | 2023 | 153 | 0.190 |
Why?
| | Acceptance and Commitment Therapy | 1 | 2021 | 27 | 0.190 |
Why?
| | Nitric Oxide Synthase | 1 | 2021 | 209 | 0.190 |
Why?
| | Nitric Oxide | 2 | 2023 | 824 | 0.180 |
Why?
| | Male | 16 | 2023 | 55579 | 0.180 |
Why?
| | Hyperemia | 1 | 2020 | 45 | 0.180 |
Why?
| | Estradiol | 1 | 2023 | 455 | 0.170 |
Why?
| | Aged, 80 and over | 3 | 2020 | 6350 | 0.170 |
Why?
| | Physical Conditioning, Human | 1 | 2020 | 26 | 0.170 |
Why?
| | Peroneal Nerve | 1 | 2019 | 19 | 0.170 |
Why?
| | Brain | 2 | 2022 | 2374 | 0.170 |
Why?
| | Oxidative Stress | 2 | 2022 | 1084 | 0.170 |
Why?
| | Receptor, Endothelin B | 1 | 2019 | 51 | 0.160 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 57 | 0.160 |
Why?
| | Association Learning | 1 | 2019 | 60 | 0.160 |
Why?
| | Students | 1 | 2023 | 501 | 0.160 |
Why?
| | Adult | 12 | 2023 | 30548 | 0.150 |
Why?
| | Young Adult | 5 | 2022 | 10463 | 0.150 |
Why?
| | Carotid Intima-Media Thickness | 3 | 2023 | 65 | 0.150 |
Why?
| | Androgens | 1 | 2019 | 167 | 0.150 |
Why?
| | Compliance | 1 | 2017 | 46 | 0.140 |
Why?
| | Alzheimer Disease | 1 | 2022 | 443 | 0.140 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 259 | 0.140 |
Why?
| | Trans Fatty Acids | 1 | 2016 | 5 | 0.140 |
Why?
| | Plant Oils | 1 | 2016 | 26 | 0.140 |
Why?
| | Soybean Oil | 1 | 2016 | 12 | 0.140 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2019 | 411 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 3 | 2022 | 3039 | 0.130 |
Why?
| | Beverages | 1 | 2016 | 60 | 0.130 |
Why?
| | Frontal Lobe | 1 | 2017 | 140 | 0.130 |
Why?
| | Hippocampus | 1 | 2019 | 695 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4409 | 0.120 |
Why?
| | Age Factors | 2 | 2019 | 2890 | 0.120 |
Why?
| | Risk Factors | 5 | 2023 | 8627 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2019 | 1472 | 0.090 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4420 | 0.080 |
Why?
| | Body Mass Index | 1 | 2017 | 1958 | 0.080 |
Why?
| | Pregnancy | 3 | 2023 | 5525 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2023 | 12515 | 0.070 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 44 | 0.060 |
Why?
| | Carotid Artery, Common | 1 | 2023 | 29 | 0.050 |
Why?
| | Lead | 1 | 2023 | 43 | 0.050 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2023 | 102 | 0.050 |
Why?
| | Writing | 1 | 2023 | 83 | 0.050 |
Why?
| | Inflammation | 2 | 2023 | 2481 | 0.050 |
Why?
| | omega-N-Methylarginine | 1 | 2021 | 25 | 0.050 |
Why?
| | Career Choice | 1 | 2023 | 177 | 0.050 |
Why?
| | Plethysmography | 1 | 2022 | 104 | 0.050 |
Why?
| | Elastin | 1 | 2021 | 78 | 0.050 |
Why?
| | Ultrasonography, Doppler | 1 | 2022 | 105 | 0.050 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2021 | 61 | 0.050 |
Why?
| | Arterioles | 1 | 2020 | 39 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2020 | 45 | 0.040 |
Why?
| | Blood Pressure Determination | 1 | 2020 | 122 | 0.040 |
Why?
| | Collagen | 1 | 2021 | 415 | 0.040 |
Why?
| | Adolescent | 3 | 2022 | 17808 | 0.040 |
Why?
| | Regional Blood Flow | 1 | 2020 | 424 | 0.040 |
Why?
| | Heart Rate | 1 | 2022 | 704 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2021 | 303 | 0.040 |
Why?
| | Antioxidants | 1 | 2022 | 530 | 0.040 |
Why?
| | Organ Size | 1 | 2019 | 435 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 675 | 0.040 |
Why?
| | Reaction Time | 1 | 2019 | 376 | 0.040 |
Why?
| | Femoral Artery | 1 | 2019 | 167 | 0.040 |
Why?
| | Coconut Oil | 1 | 2016 | 2 | 0.030 |
Why?
| | Iowa | 1 | 2016 | 24 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3005 | 0.030 |
Why?
| | Nitrates | 1 | 2016 | 71 | 0.030 |
Why?
| | Nitrites | 1 | 2016 | 74 | 0.030 |
Why?
| | Postprandial Period | 1 | 2016 | 87 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 1843 | 0.030 |
Why?
| | Anxiety | 1 | 2021 | 842 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 926 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2016 | 440 | 0.030 |
Why?
| | Administration, Oral | 1 | 2016 | 731 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 1717 | 0.030 |
Why?
| | Hypertension | 1 | 2020 | 1059 | 0.030 |
Why?
| | Prospective Studies | 1 | 2020 | 6217 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2016 | 1072 | 0.020 |
Why?
| | Biomarkers | 1 | 2016 | 3416 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 6124 | 0.020 |
Why?
|
|
DuBose's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|